Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2017 Filed Jan 3, 2018 20:00 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000005 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:00 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Tax withholdingCommon Stock | 103 | $15.15 | $1,560.45 |
DisclosureSEC source: 0000898432-18-000005 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,831 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:00 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000005 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:04 UTC |
Waldman Louis S.CONTROLLER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,164 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000006 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · CONTROLLER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,328 Underlying: Common Stock · 1,164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:04 UTC |
Waldman Louis S.CONTROLLER
|
Tax withholdingCommon Stock | 319 | $15.15 | $4,832.85 |
DisclosureSEC source: 0000898432-18-000006 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · CONTROLLER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,221 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:04 UTC |
Waldman Louis S.CONTROLLER
|
Exercise / conversionCommon Stock | 1,164 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000006 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · CONTROLLER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:09 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionRestricted Stock Unit · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000009 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:09 UTC |
Nardi Steven M.VP MANUFACTURING
|
Tax withholdingCommon Stock | 107 | $15.15 | $1,621.05 |
DisclosureSEC source: 0000898432-18-000009 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:09 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000009 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 01:07 UTC |
JOHNSON BRENTEXEC. VP. SALES & MARKETING
|
Exercise / conversionRestricted Stock Units · Derivative | 617 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000008 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · EXEC. VP. SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234 Underlying: Common Stock · 617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 01:07 UTC |
JOHNSON BRENTEXEC. VP. SALES & MARKETING
|
Tax withholdingCommon Stock | 169 | $15.15 | $2,560.35 |
DisclosureSEC source: 0000898432-18-000008 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · EXEC. VP. SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 01:07 UTC |
JOHNSON BRENTEXEC. VP. SALES & MARKETING
|
Exercise / conversionCommon Stock | 617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000008 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · EXEC. VP. SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 01:05 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,899 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000007 · form4.xml · derivative · entry 3 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,899 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 01:05 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 1,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000007 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:57 UTC |
Scott Christopher K.CHIEF FINANCIAL OFFICER & SECY
|
Exercise / conversionRestricted Stock Units · Derivative | 2,716 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000004 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,431 Underlying: Common Stock · 2,716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:57 UTC |
Scott Christopher K.CHIEF FINANCIAL OFFICER & SECY
|
Tax withholdingCommon Stock | 743 | $15.15 | $11,256.45 |
DisclosureSEC source: 0000898432-18-000004 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:57 UTC |
Scott Christopher K.CHIEF FINANCIAL OFFICER & SECY
|
Exercise / conversionCommon Stock | 2,716 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000004 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:01 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001304 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275 Underlying: Common Stock · 425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:01 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Tax withholdingCommon Stock | 139 | $13.10 | $1,820.90 |
DisclosureSEC source: 0000898432-17-001304 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,546 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:01 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Exercise / conversionCommon Stock | 425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001304 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 17:54 UTC |
Waldman Louis S.CONTROLLER
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001303 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · CONTROLLER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 17:54 UTC |
Waldman Louis S.CONTROLLER
|
Tax withholdingCommon Stock | 245 | $13.10 | $3,209.50 |
DisclosureSEC source: 0000898432-17-001303 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · CONTROLLER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,376 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 17:54 UTC |
Waldman Louis S.CONTROLLER
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001303 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · CONTROLLER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:19 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001309 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:19 UTC |
Nardi Steven M.VP MANUFACTURING
|
Tax withholdingCommon Stock | 245 | $13.10 | $3,209.50 |
DisclosureSEC source: 0000898432-17-001309 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:19 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001309 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:08 UTC |
Kennedy JonathanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,347 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001306 · form4.xml · derivative · entry 2 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,348 Underlying: Common Stock · 4,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:08 UTC |
Kennedy JonathanDirector
|
Exercise / conversionCommon Stock | 4,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001306 · form4.xml · nonDerivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:15 UTC |
Scott Christopher K.CHIEF FINANCIAL OFFICER & SECR
|
Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001308 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,251 Underlying: Common Stock · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stiock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:15 UTC |
Scott Christopher K.CHIEF FINANCIAL OFFICER & SECR
|
Tax withholdingCommon Stock | 1,116 | $13.10 | $14,619.60 |
DisclosureSEC source: 0000898432-17-001308 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,128 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:15 UTC |
Scott Christopher K.CHIEF FINANCIAL OFFICER & SECR
|
Exercise / conversionCommon Stock | 3,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001308 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stiock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:11 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,347 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001307 · form4.xml · derivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,348 Underlying: Common Stock · 4,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:11 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 4,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001307 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:04 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,347 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001305 · form4.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,348 Underlying: Common Stock · 4,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:04 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 4,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001305 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:48 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001302 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:48 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Tax withholdingCommon Stock | 245 | $13.10 | $3,209.50 |
DisclosureSEC source: 0000898432-17-001302 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:48 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001302 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:47 UTC |
McCreery John KChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045233 · doc1.xml · derivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:49 UTC |
Casey Francis X.VP of Reg & Qual Assurance
|
GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045235 · doc1.xml · derivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:45 UTC |
Waldman Louis S.Controller
|
GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045232 · doc1.xml · derivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:43 UTC |
Nardi Steven M.VP of Manufacturing
|
GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045229 · doc1.xml · derivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:47 UTC |
Kennedy JonathanDirector
|
GrantRestricted Stock Units · Derivative | 7,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045234 · doc1.xml · derivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,380 Underlying: Common Stock · 7,380 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 7, 2017 00:50 UTC |
ALLEN MONTY KDirector
|
GrantRestricted Stock Units · Derivative | 7,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045236 · doc1.xml · derivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,380 Underlying: Common Stock · 7,380 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 7, 2017 00:50 UTC |
ALLEN MONTY KDirector
|
SaleCommon Stock | 1,898 | $13.95 | $26,477.10 |
DisclosureSEC source: 0001140361-17-045236 · doc1.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,062 Read SEC document |
| December 04, 2017 Filed Dec 7, 2017 00:44 UTC |
JOHNSON BRENTExec. VP, Sales & Marketing
|
GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045230 · doc1.xml · derivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 7, 2017 00:41 UTC |
VUOTO ANTHONYDirector
|
GrantRestricted Stock Units · Derivative | 7,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045226 · doc1.xml · derivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,380 Underlying: Common Stock · 7,380 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2017 Filed Dec 7, 2017 00:40 UTC |
Scott Christopher K.CFO & Secretary
|
GrantRestricted Stock Units · Derivative | 11,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045225 · doc1.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,808 Underlying: Common Stock · 11,808 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 19:04 UTC |
Kennedy JonathanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-026707 · doc1.xml · derivative · entry 2 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,916 Underlying: Common Stock · 2,458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 27, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on June 27, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On June 27, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on June 27, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 19:04 UTC |
Kennedy JonathanDirector
|
Exercise / conversionCommon Stock | 2,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-026707 · doc1.xml · nonDerivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.